[CAPR] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[CAPR] Capricor Therapeutics, Inc.
Announcement Date
08-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 21.46%
YoY- 61.15%
Quarter Report
CAPR's Result
CAPR's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 50 186 222 142 410 231 648 -81.90%
PBT -3,484 -2,085 -1,469 -1,607 -2,046 -2,519 -3,260 4.53%
Tax -36 -23 -57 -64 -62 -38 -43 -11.18%
NP -3,484 -2,085 -1,469 -1,607 -2,046 -2,519 -3,260 4.53%
Tax Rate - - - - - - - -
Total Cost 3,534 2,271 1,692 1,749 2,457 2,750 3,908 -6.49%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -6,987.31 -1,122.72 -661.60 -1,130.84 -498.71 -1,092.97 -503.00 478.79%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.23 -0.30 -0.34 -0.43 -0.59 -0.75 -1.05 -63.69%
EPS Diluted -0.23 -0.30 -0.34 -0.43 -0.59 -0.75 -1.05 -63.69%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.